Catalyst Pharmaceuticals (CPRX) Capital Expenditures (2011 - 2026)

Catalyst Pharmaceuticals' (CPRX) quarterly Capital Expenditures came in at $27000.0 in Q1 2026, down 15.62% on a QoQ basis from $32000.0 in Q4 2025.

Catalyst Pharmaceuticals (CPRX) Capital Expenditures (2011 - 2026) Analysis & Trends

Catalyst Pharmaceuticals (CPRX) has 13 years of Capital Expenditures data on file, last reported at $27000.0 in Q1 2026.

Quarterly Capital Expenditures changed N/A year-over-year to $27000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85000.0 (down 76.19% YoY) and the FY2025 annual result came in at $58000.0, down 89.57% from the prior year.
Capital Expenditures fell to $27000.0 in Q1 2026, from $32000.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $259000.0 in Q3 2024 to a low of $10000.0 in Q2 2024.
A 4-year average of $87200.0 and a median of $69000.0 in 2023 frame the typical range for Capital Expenditures.
Annual changes were most pronounced in 2024 — Capital Expenditures jumped 304.69% — and 2025, when it tumbled 63.64%.
Tracing CPRX's Capital Expenditures over 4 years: stood at $93000.0 in 2023, then decreased by 5.38% to $88000.0 in 2024, then plunged by 63.64% to $32000.0 in 2025, then dropped by 15.62% to $27000.0 in 2026.
The last three Capital Expenditures figures came in at $27000.0 (Q1 2026), $32000.0 (Q4 2025), and $26000.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.29 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.02 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	572,662.23
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	251.02 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	34.68 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.26 Mn
10	Catalyst Pharmaceuticals	3.85 Bn	3.09 Bn	134.92 Mn	27,000.00

Download Data